Please note: This webinar is part of the Congress 2024 webinar library package which is no longer available for purchase. If your Congress Webinar Library 2024 subscription is still active, you can still watch this webinar.
Overview
This session would provide up-to-date and comprehensive accounts of potential hazards associated with prescription of commonly prescribed psychotropic drugs during pregnancy. The talks would focus on the mood stabilisers sodium valproate, lamotrigine and lithium. The evidence in this field changes regularly and clinicians may not be fully aware of current and emerging evidence or of guidance from regulatory bodies on prescriptions in this potentially vulnerable patient group.
Learning objectives
Participants will have:
- increased knowledge of potential hazards associated with psychotropic drug prescriptions in a vulnerable patient group
- increased confidence in discussions with patients and relatives about this aspect of clinical practice
- increased familiarity with regulatory guidance relating to commonly prescribed medicines.
Speakers
Professor David Baldwin, University of Southampton, Southampton
Professor David Cunningham Owens, University of Edinburgh, Edinburgh
Professor Ian Jones, Cardiff University, Cardiff
Availability
This webinar is part of the Congress 2024 webinar library package which is no longer available for purchase. If your Congress Webinar Library 2024 subscription is still active, you can still watch this webinar.
